Game-changing diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable ...

The diabetes business generated nearly $2.8 billion in sales in its most recent fiscal year, ending in April, up 10.7% from the prior year. Medtronic reported more than $34 billion in sales last year.

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs ...

These days, more and more of us have to worry about our blood sugar. Some 38 million Americans have diabetes, and more than two times that number have pre-diabetes.Many millions more have some ...

Diabetes is sneaky. It doesn’t always show up with a neon sign saying, “Hey, something’s wrong!” Instead, it quietly settles in, dropping little hints that can be super easy to miss.

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 diabetes lose an average of nearly 8% of their body weight after 40 weeks ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 diabetes lose an average of nearly 8% of their body weight after 40 weeks ...

Michelle Trachtenberg died from diabetes complications at 39. The condition is called the “silent killer" and can develop after an organ transplant, an expert tells PEOPLE.

From oral drops falsely marketed as GLP-1 alternatives to unauthorized smartwatches claiming to monitor blood sugar without a single finger prick, a wave of fraudulent diabetes-related products ...

Death rates from diabetes peaked in 2021, according to CDC figures, at 31.1 deaths per 100,000 people for that year. Diabetes was the eighth leading cause of death in 2021.

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type 2 diabetes. Previous versions were administered via injection.